Zijun Qian

No ORCID on file · 1 paper in corpus
lab-animal 2018
Drug design, development and therapy ·doi:10.2147/dddt.s166330

Bevacizumab, which is a humanized anti-VEGF antibody, has been successfully applied in clinics since 2004. Bevacizumab in combination with chemotherapy showed high safety and has been applied to solid tumors. However, studies on the insight…